3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Myeloid, Acute
4
Hematologic Neoplasms
4
Melanoma
3
Lymphoma
3
Sarcoma
2
Recurrence
2
Osteosarcoma
2
Neuroblastoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, B-Cell
2
Leukemia
2
Wilms Tumor
1
Teratoma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neurofibrosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Histologic Type
1
Meningeal Neoplasms
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Mesna
×
90 days
×
Clear all
No trials found.